Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,625 | -15,207 | -20,236 | 30,259 | 15,042 |
| Depreciation Amortization | 24,286 | 15,294 | 6,835 | 18,958 | 13,547 |
| Income taxes - deferred | 1,817 | -5,199 | -8,052 | 13,858 | 4,667 |
| Accounts receivable | 36,106 | 2,274 | 17,590 | 35,456 | 65,950 |
| Accounts payable and accrued liabilities | -11,176 | -10,357 | -10,713 | -551 | -1,622 |
| Other Working Capital | 18,293 | -18,110 | -8,568 | 24,143 | 48,579 |
| Other Operating Activity | -15,454 | 12,879 | -6,101 | -25,155 | -57,836 |
| Operating Cash Flow | $60,497 | $-18,426 | $-29,245 | $96,968 | $88,327 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,621 | -9,400 | -4,590 | -42,021 | -34,420 |
| Net Acquisitions | -178,167 | -178,167 | -178,167 | -25,873 | -24,120 |
| Investing Cash Flow | $-192,788 | $-187,567 | $-182,757 | $-67,894 | $-58,540 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 242,654 | 242,654 | 242,654 | 62,000 | N/A |
| Debt Repayment | -62,000 | -62,000 | -62,000 | -62,774 | -3,352 |
| Common Stock Issued | 10,656 | 9,969 | 8,137 | 6,848 | 2,505 |
| Common Stock Repurchased | N/A | N/A | N/A | -213 | N/A |
| Other Financing Activity | 3,875 | 4,160 | 4,083 | 2,751 | 1,949 |
| Financing Cash Flow | $195,185 | $194,783 | $192,874 | $8,612 | $1,102 |
| Exchange Rate Effect | 17 | 2 | 5 | -14 | 6 |
| Beginning Cash Position | 179,338 | 179,338 | 179,338 | 141,666 | 141,666 |
| End Cash Position | 242,249 | 168,130 | 160,215 | 179,338 | 172,561 |
| Net Cash Flow | $62,911 | $-11,208 | $-19,123 | $37,672 | $30,895 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60,497 | -18,426 | -29,245 | 96,968 | 88,327 |
| Capital Expenditure | -14,621 | -9,400 | -4,590 | -42,021 | -34,420 |
| Free Cash Flow | 45,876 | -27,826 | -33,835 | 54,947 | 53,907 |